David Mehalick's most recent trade in Coeptis Therapeutics Holdings Inc was a trade of 148,875 Common stock done at an average price of $7.1 . Disclosure was reported to the exchange on Feb. 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.05 per share. | 11 Feb 2026 | 148,875 | 330,192 | - | 7.1 | 1,049,569 | Common stock |
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 51,250 | 330,192 | - | 0 | Common Stock | |
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 28,875 | 200,125 | - | - | Non-Qualified Stock Options (right to buy) | |
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.66 per share. | 05 Jan 2024 | 14,004 | 2,782,615 | - | 0.7 | 9,243 | Common Stock |
| Coeptis Therapeutics Holdings Inc | Mehalick David | Director, CEO and President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 05 Jan 2024 | 6,000 | 2,768,611 | - | 0.7 | 4,020 | Common Stock |
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 05 Jan 2024 | 5,050 | 2,762,611 | - | 0.7 | 3,485 | Common Stock |
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Dec 2023 | 700,000 | 2,757,561 | - | 0 | Common Stock | |
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 375,000 | 375,000 | - | - | Non-qualified Stock Options (right to buy) | |
| Coeptis Therapeutics Holdings Inc | David Mehalick | Director, CEO and President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 250,000 | 250,000 | - | - | Incentive Stock Options (right to buy) |